Search

Former Abt Global staff published a Global Health Action study on malaria case-management in the DRC, showing strong adherence to national testing/treatment guidance with clear, actionable opportunities to improve diagnostic accuracy, patient follow-up, and RDT availability.

Abt Global, through PMI Evolve, is piloting a new US-made malaria fighting technology in six African countries—now being scaled up through a new partnership with SC Johnson, the U.S. Department of State, and the Global Fund.

Abt is proud to celebrate TJ Shumard, who has been named a 2026 IGNITE Powerful Leaders Igniting Digital Transformation Honoree.

A new Centers for Disease Control and Prevention study confirms that mask use, vaccinations, and boosters reduce the risk of COVID-19 reinfection.

Chronic obstructive pulmonary disease is a serious and growing health issue in Nepal, but targeting risk factors can reduce the disease burden.

This paper outlines the reasons government agencies will need a digital plan to transition out of ColdFusion and different migration paths they can take.

Abt Global is bringing clients the benefits of AI pragmatically, effectively, and safely.